Search

Your search keyword '"Pardini, Matteo"' showing total 922 results

Search Constraints

Start Over You searched for: Author "Pardini, Matteo" Remove constraint Author: "Pardini, Matteo"
922 results on '"Pardini, Matteo"'

Search Results

4. Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer’s Disease

5. Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease

6. Predicting disease severity in multiple sclerosis using multimodal data and machine learning

7. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission

8. Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort

9. Correction: Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I‑UDSNB 1.0): development and normative data

11. Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)

12. The reliability of a deep learning model in clinical out-of-distribution MRI data: a multicohort study

13. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial

17. Dog-assisted physiotherapy in amyotrophic lateral sclerosis: a randomized controlled pilot study

22. Neurological long-COVID in the outpatient clinic: Two subtypes, two courses

24. Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease

27. Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data

32. Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research study

33. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

42. Forest 3D Radar Reflectivity Reconstruction at X-Band Using a Lidar Derived Polarimetric Coherence Tomography Basis.

43. Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.

47. Predicting disease severity in multiple sclerosis using multimodal data and machine learning

48. Medical Information Extraction with NLP-Powered QABots: a Real-World Scenario

50. Monoaminergic Disfunctions and Misfolded Proteins levels in the Alzheimer’s Disease Continuum

Catalog

Books, media, physical & digital resources